Jane Street Group, LLC Ardelyx, Inc. Call Options Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$5.28 - $7.57 $277,200 - $397,425	52,500 New	52,500 $361,000
Q1 2022 May 17, 2022	SELL	$0.65 - $1.18 $114,075 - $207,090	-175,500 Reduced 77.9%	49,800 $53,000
Q4 2021 Feb 15, 2022	BUY	$0.86 - $1.7 $162,540 - $321,300	189,000 Added 520.66%	225,300 $248,000
Q3 2021 Nov 16, 2021	SELL	$1.27 - $8.17 $9,017 - $58,007	-7,100 Reduced 16.36%	36,300 $48,000
Q2 2021 Aug 16, 2021	BUY	$6.55 - $8.98 $284,270 - $389,732	43,400 New	43,400 $329,000

213

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $775M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.